Moderna Emergency Use Authorization

An Emergency Use Authorization (EUA) for COVID-19 vaccine (Moderna) was issued by the Food and Drug Administration (FDA) on December 18, 2020.

An EUA allows access to critical medical products that may help during a public health emergency. An EUA is different from approval/licensure. 

The following criteria must be met for an EUA to be issued: 

  • The product will be used for a serious or life-threatening disease or condition.
  • Based on the totality of scientific evidence available, it is reasonable to believe the product may be effective. 
  • The known and potential benefits of the product outweigh the known and potential risks of the product. 
  • There is no adequate FDA-approved alternative available.

Emergency Use Authorization of Moderna COVID-19 Vaccine



Page last reviewed: July 16, 2021